Catalyst Wire Dossier Catalyst Wire Dossier

RLD2302

· Hanmi Pharmaceutical Company Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RLD2302, covering 2025-02-20 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers [Phase 1]

See pricing